IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sahajanand Medical Technologies IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Surat and caters to Healthcare sector. Avendus Capital , Hsbc Securities & Capital Markets Limited , Motilal Oswal Investment Advisors , Nuvama Wealth Management are the merchant bankers of Sahajanand Medical Technologies IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th July 2025.
Sahajanand Medical Technologies IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
978.00 cr.
Sector: Healthcare
IPO so far:
28
Merchant Banker:
Avendus Capital
IPO by BRLM so far:
2
City:
Surat
IPO so far:
5
Revenue (annualised):
₹
1024.88
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 27.92x
Sahajanand Medical Technologies IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Avendus Capital Private Limited is the book-running lead manager of the Sahajanand Medical Technologies IPO. MUFG Intime India Private Limited (prev known as Linkintime India Private Limited) is the Registrar for Sahajanand Medical Technologies IPO.
Sahajanand Medical Technologies IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Sahajanand Medical Technologies IPO, based in Surat, operates in the Healthcare sector with a focus on Developer of Class III and Class C/D medical devices, with a strong focus on vascular and structural heart interventions.. The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Sahajanand Medical Technologies IPO size is ₹ [●] with fresh issue size of ₹ 0 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Sahajanand Medical Technologies IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Sahajanand Medical Technologies IPO allotment status on the registrars website, MUFG Intime India Private Limited (prev known as Linkintime India Private Limited) . Sahajanand Medical Technologies IPO refund dates are [●].
Sahajanand Medical Technologies IPO is expected to be listed on [●].
The upper price band for the Sahajanand Medical Technologies IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Sahajanand Medical Technologies IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Sahajanand Medical Technologies IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Sahajanand Medical Technologies IPO is finalised.
The merchant banker for Sahajanand Medical Technologies IPO is Avendus Capital Private Limited , Hsbc Securities & Capital Markets Private limited , Motilal Oswal Investment Advisors Limited , Nuvama Wealth Management Limited . Avendus Capital Private Limited , Hsbc Securities & Capital Markets Private limited , Motilal Oswal Investment Advisors Limited , Nuvama Wealth Management Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Sahajanand Medical Technologies IPO RHP for further details.
The registrar for Sahajanand Medical Technologies IPO is MUFG Intime India Private Limited (prev known as Linkintime India Private Limited) . Investors can go to MUFG Intime India Private Limited (prev known as Linkintime India Private Limited) registrar website for IPO allotment status, refund processing, and other queries related to Sahajanand Medical Technologies IPO through their official website or helpline.
Sahajanand Medical Technologies IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 978.00 Cr.
Sector: Healthcare
IPO so far:
28
Merchant Banker:
Avendus Capital
IPO by BRLM so far:
2
City:
Surat
IPO so far:
5
Revenue (annualised):
₹ 1,024.88 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 27.92x
Sahajanand Medical Technologies IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Sahajanand Medical Technologies Financial Review Page
Merchant Banker(s) of Sahajanand Medical Technologies IPO: Avendus Capital Private Limited , Hsbc Securities & Capital Markets Private limited , Motilal Oswal Investment Advisors Limited , Nuvama Wealth Management Limited
Sahajanand Medical Technologies IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sahajanand Medical Technologies IPO listed at a listing price of against the offer price of .
The current market price of Sahajanand Medical Technologies is .
Why Us?
